About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Intensive Care Program for Youth With Diabetes | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT00961974

Intensive Care Program for Youth With Diabetes

The purpose of this study was to determine the ability of a family-focused, office-based intervention to improve medical and behavioral outcomes for children and adolescents with type 1 diabetes.

Lead sponsor: Joslin Diabetes Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Joslin Diabetes Center

Collaborators

Charles H. Hood Foundation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Age

8 - 16 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Age 8-16 years
•Type 1 diabetes diagnosed by standard American Diabetes Association criteria
•Type 1 diabetes duration of at least 6 months
•Residence in northeastern U.S.
•Established clinic patient
•Fluency in English or Spanish

Exclusion Criteria

•Major psychiatric disorder (e.g., major depression, severe eating disorder, mental retardation)
•Unstable living environment (e.g., Department of Social Services or Department of Youth Services involvement)

Related studies

RECRUITINGPhase 2

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

NCT07224321 · Type 1 Diabetes Mellitus

RECRUITINGEARLY Phase 1

Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes

NCT07395050 · Stage 3 Type 1 Diabetes

Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)

NCT07457580 · Type 1 Diabetes

Capillary OGTT Study

NCT06815081 · Type 1 Diabetes (T1D), Type 2 Diabetes

RECRUITINGPhase 2

An Adaptive Design Study of MTX228

NCT06474598 · Type 1 Diabetes Mellitus

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 4, 2021Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment154

Start dateApr 2002

Last updatedAug 4, 2021

Condition

Type 1 Diabetes

Locations shown

Joslin Diabetes Center

Boston, Massachusetts

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 4, 2021Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions